Inspra

Eplerenone, the active ingredient in Inspra, is an aldosterone antagonist presented as an oral tablet for oral use. It is employed to manage high blood pressure and to improve outcomes in patients with heart failure, including those with left ventricular dysfunction after myocardial infarction.

GNH USA supplies Inspra as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, adhering to stringent quality standards and providing reliable global distribution. Our supply chain ensures product integrity from manufacturing to delivery.

Inspra (eplerenone) acts as an aldosterone antagonist to treat conditions related to fluid overload and elevated blood pressure.

Hypertension: reduces blood pressure by decreasing sodium and water retention. Heart failure: improves survival and lowers hospitalization rates in patients with reduced ejection fraction. Post‑myocardial infarction (left ventricular dysfunction): lowers risk of cardiovascular death and heart‑failure progression after an MI.

Eplerenone may cause a range of adverse reactions, which are grouped by frequency.

Common Side Effects: - Hyperkalaemia: elevated serum potassium levels. - Dizziness or light‑headedness. - Headache. - Fatigue. - Mild gastrointestinal discomfort.

Serious or Rare Side Effects: - Severe hyperkalaemia leading to cardiac arrhythmia. - Acute renal impairment or worsening kidney function. - Allergic reactions including rash or pruritus. - Angioedema affecting face, lips or airway. - Hepatic dysfunction with elevated liver enzymes.

Before initiating therapy, clinicians should assess patient-specific risk factors and monitor laboratory parameters.

Monitor serum potassium: check levels regularly to detect hyperkalaemia. Assess renal function: evaluate creatinine clearance prior to and during treatment. Use caution in the elderly: age‑related renal decline may increase adverse risk. Avoid in patients with existing hyperkalaemia: contraindicated when serum potassium is >5.0 mmol/L. Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Eplerenone can interact with several drug classes, requiring careful management.

Major Interactions (Avoid): - Potassium‑sparing diuretics (e.g., amiloride, triamterene). - ACE inhibitors or angiotensin‑II receptor blockers. - Cyclosporine or other potent CYP3A4 inhibitors. - Non‑steroidal anti‑inflammatory drugs (NSAIDs) in patients with renal impairment.

Moderate Interactions (Monitor Closely): - Digoxin: monitor serum levels for toxicity. - Lithium: observe for increased lithium concentrations. - Thiazide diuretics: watch for combined electrolyte disturbances.